Table 1 Putative vaccine candidates used in the vaccination model evaluated in terms of subcellular localization, antigenicity, adhesion, number of transmembrane helices, and number of IgG and IgA epitopes through the Psortb, VaxiJen, Vaxign, and TMHMM v2.0, HMMTOP 2.0., and Igperd

From: Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice

Protein code

Protein Uniprot entry

Accession number

Protein annotation

Localization by Psortb

Similarity to human and mouse

Stability prediction (ProtParam threshold ≤ 40)

Adhesion probability

Antigenicity score

threshold > 0.5

Number of Transmembrane helices

Number of IgG epitopes

Number of IgA epitopes

LY

B4EJ27

WP_006481710.1

Phospholipase C

Extracellular

None

28.58

0.875

0.6678

0

39

22

KT

B4EKU7

WP_012493605.1

Phosphodiesterase superfamily protein AtaC domain

Extracellular

None

20.64

0.702

0.6074

0

47

20

BD

B4EJA5

WP_006492970.1

Chitinase class I domain

Extracellular

None

25.12

0.919

1.0521

0

27

9